← Back to headlines
AstraZeneca Finalizes Licensing Agreement for Lung Cancer Drug Zegfrovy
Pharmaceutical giant AstraZeneca has completed a licensing deal for its lung cancer treatment Zegfrovy, marking a significant step in its oncology portfolio expansion.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon Cargo Plane Overshoots Runway at Miami Airport, Killing Five
42m ago
Japan’s Foreign Reserves Plunge Record $79.6 Billion After Yen Intervention
2h ago
Record-Breaking White Falcon Fetches 2.1 Million Dirhams at Abu Dhabi Auction
2h ago
Japan Likely Sold US Treasuries to Fund Record Yen Intervention
2h ago